Evidence map›Paper›PMID 30358156›Full record

ArticleObesity (Silver Spring, Md.)2018

L-Arginine Increases Postprandial Circulating GLP-1 and PYY Levels in Humans.

Anjali Amin, Christina Neophytou, Shermaine Thein, Niamh M Martin, Amin Alamshah, Eleanor Spreckley, Stephen R Bloom, Kevin G Murphy

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06790771 (Acute Effect of Supplement Containing L-Arginine on Appetite Suppression and GLP-1 Induction), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06790771 nacompletednot on this mapstarted 2025, after this paper: background citation

Acute Effect of Supplement Containing L-Arginine on Appetite Suppression and GLP-1 Induction

TypeinterventionalSponsorTexas Christian UniversityRan2025 to 2026Enrolled25ConditionsHungerArmsHigh Dose Supplement, Low Dose Supplement, Placebo
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review.Advances in nutrition (Bethesda, Md.) · 2021
    Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anjali AminSection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.ORCID 0000-0002-0416-6505
Christina NeophytouSection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Shermaine TheinSection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Niamh M MartinSection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Amin AlamshahSection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Eleanor SpreckleySection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Stephen R BloomSection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Kevin G MurphySection of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Imperial College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I001816/1Medical Research Council MR/J010944/1
6 · The paper itself

Abstract

objectiveThe satiating effect of protein compared with other nutrients has been well described and is thought to be mediated, in part, by gut hormone release. Previously, it has been shown that oral L-arginine acts as a GLP-1 secretagogue both in vitro and in vivo in rodents. Here, the effect of L-arginine on gut hormone release in humans was investigated.

methodsThe hypothesis was tested in two separate studies. The first study assessed the tolerability of oral L-arginine in healthy human subjects. The second study assessed the effect of oral L-arginine on gut hormone release following an ad libitum meal. Subjects were given L-arginine, glycine (control amino acid), or vehicle control in a randomized double-blind fashion.

resultsAt a dose of 17.1 mmol, L-arginine was well tolerated and stimulated the release of plasma GLP-1 (P < 0.05) and PYY (P < 0.001) following an ad libitum meal. Food diaries showed a trend toward lower energy intake and particularly fat intake following L-arginine treatment.

conclusionsL-arginine can significantly elevate GLP-1 and PYY in healthy human volunteers in combination with a meal. Further work is required to investigate whether L-arginine may have utility in the suppression of appetite and food intake.

Indexed as

AdultAppetite DepressantsArginineDouble-Blind MethodEatingFemaleGlucagon-Like Peptide 1HumansMalePeptide YYPostprandial PeriodAppetite DepressantsArginineGlucagon-Like Peptide 1Peptide YY

Identifiers

PMID30358156
PMCPMC6220957
OpenAlexW2898589869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.